These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 18788409)

  • 1. [Measures against hyperuricemia].
    Ohno I; Hosoya T
    Nihon Rinsho; 2008 Sep; 66(9):1779-85. PubMed ID: 18788409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease.
    Talaat KM; el-Sheikh AR
    Am J Nephrol; 2007; 27(5):435-40. PubMed ID: 17622758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions.
    Kanbay M; Ozkara A; Selcoki Y; Isik B; Turgut F; Bavbek N; Uz E; Akcay A; Yigitoglu R; Covic A
    Int Urol Nephrol; 2007; 39(4):1227-33. PubMed ID: 17701281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between hyperuricemia and chronic kidney disease.
    Ohno I
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1039-44. PubMed ID: 22132954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review investigating the effect of allopurinol on the progression of kidney disease in hyperuricemic patients with chronic kidney disease.
    Kabul S; Shepler B
    Clin Ther; 2012 Dec; 34(12):2293-6. PubMed ID: 23140758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allopurinol reduces cardiovascular risks and improves renal function in pre-dialysis chronic kidney disease patients with hyperuricemia.
    Sezer S; Karakan S; Atesagaoglu B; Acar FN
    Saudi J Kidney Dis Transpl; 2014 Mar; 25(2):316-20. PubMed ID: 24625997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyperuricaemia and Chronic Kidney Disease].
    Garofalo C; De Stefano T; Vita C; Vinci G; Balia F; Nettuno F; Scarpati L; Sguazzo A; Sagliocchi A; Pacilio M; Minutolo R; De Nicola L; Borrelli S
    G Ital Nefrol; 2018 Feb; 35(1):. PubMed ID: 29390240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggravation of immunoglobulin a nephropathy by hyperuricemia: a mini-review on current findings and new concepts.
    Nasri H; Baradaran A
    Iran J Kidney Dis; 2014 Sep; 8(5):359-62. PubMed ID: 25194401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on gout and hyperuricemia.
    Baker JF; Schumacher HR
    Int J Clin Pract; 2010 Feb; 64(3):371-7. PubMed ID: 19909378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uric acid: a novel mediator and marker of risk in chronic kidney disease?
    Feig DI
    Curr Opin Nephrol Hypertens; 2009 Nov; 18(6):526-30. PubMed ID: 19654543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xanthine oxidase and the beneficial effect of allopurinol on blood pressure and renal function.
    Duan X
    Int Urol Nephrol; 2008; 40(4):1111. PubMed ID: 18686009
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of hyperuricemia in essential hypertension.
    Trachtman H
    Hypertension; 2007 Jun; 49(6):e45; author reply e46. PubMed ID: 17389252
    [No Abstract]   [Full Text] [Related]  

  • 14. Uric acid in hypertension and renal disease: the chicken or the egg?
    Kanbay M; Solak Y; Dogan E; Lanaspa MA; Covic A
    Blood Purif; 2010; 30(4):288-95. PubMed ID: 21088389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The uric acid cardio-nephropathy].
    Viazzi F; Bonino B; Cappadona F; Pontremoli R
    G Ital Nefrol; 2017 Mar; 34(Suppl 69):41-48. PubMed ID: 28682028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperuricemia and the progression of chronic kidney disease: is uric acid a marker or an independent risk factor?
    Nashar K; Fried LF
    Adv Chronic Kidney Dis; 2012 Nov; 19(6):386-91. PubMed ID: 23089273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time to target uric acid to retard CKD progression.
    Kumagai T; Ota T; Tamura Y; Chang WX; Shibata S; Uchida S
    Clin Exp Nephrol; 2017 Apr; 21(2):182-192. PubMed ID: 27339448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation: a possible mechanism for a causative role of hyperuricemia/gout in cardiovascular disease.
    Perez-Ruiz F; Becker MA
    Curr Med Res Opin; 2015; 31 Suppl 2():9-14. PubMed ID: 26414731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lozartan potential in hyperuricemia correction].
    Ter Arkh; 2011; 83(10):45-8. PubMed ID: 22185025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allopurinol Use and Risk of Fatal Hypersensitivity Reactions: A Nationwide Population-Based Study in Taiwan.
    Yang CY; Chen CH; Deng ST; Huang CS; Lin YJ; Chen YJ; Wu CY; Hung SI; Chung WH
    JAMA Intern Med; 2015 Sep; 175(9):1550-7. PubMed ID: 26193384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.